Market Research

Thin Film Drug Manufacturing Market (Product: Oral Thin Film, Transdermal Thin Film, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2034

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 197 Pages Transparency Market Research Pvt. Ltd. April, 2024 TNPR18827848
Best Price Guarantee
Price from $5,795
Length 197 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date April, 2024
SKU TNPR18827848

Thin Film Drug Manufacturing Market (Product: Oral Thin Film, Transdermal Thin Film, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2034


Thin Film Drug Manufacturing Market – Scope of Report

TMR’s report on the global thin film drug manufacturing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global thin film drug manufacturing market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global thin film drug manufacturing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the thin film drug manufacturing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global thin film drug manufacturing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global thin film drug manufacturing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global thin film drug manufacturing market.

The report delves into the competitive landscape of the global thin film drug manufacturing market. Key players operating in the global thin film drug manufacturing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global thin film drug manufacturing market profiled in this report.

Key Questions Answered in Global thin film drug manufacturing Market Report
  • What is the sales/revenue generated by thin film drug manufacturing across all regions during the forecast period?
  • What are the opportunities in the global thin film drug manufacturing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Thin Film Drug Manufacturing Market – Research Objectives and Research Approach

The comprehensive report on the global thin film drug manufacturing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global thin film drug manufacturing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global thin film drug manufacturing market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Thin Film Drug Manufacturing Market
4. Market Overview
  4.1. Introduction
  4.1.1. Product Definition
  4.1.2. Industry Evolution/Developments
  4.2. Overview
  4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
  4.4. Thin Film Drug Manufacturing Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product /Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Global Thin Film Drug Manufacturing Market Analysis and Forecast, by Product
  6.1. Introduction & Definition
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Product, 2020-2034
  6.3.1. Oral Thin Film
  6.3.1.1. Sublingual Film
  6.3.1.2. Fully Dissolving Dental/Buccal Film
  6.3.2. Transdermal Thin Film
  6.3.3. Others
  6.4. Market Attractiveness Analysis, by Product
7. Global Thin Film Drug Manufacturing Market Analysis and Forecast, by Disease Indication
  7.1. Introduction & Definition
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Disease Indication, 2020-2034
  7.3.1. Schizophrenia
  7.3.2. Migraine
  7.3.3. Opioid Dependence
  7.3.4. Nausea & Vomiting
  7.3.5. Others
  7.4. Market Attractiveness Analysis, by Disease Indication
8. Global Thin Film Drug Manufacturing Market Analysis and Forecast, by Distribution Channel
  8.1. Introduction & Definition
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by Distribution Channel, 2020-2034
  8.3.1. Hospital Pharmacies
  8.3.2. Drug Stores
  8.3.3. Retail Pharmacies
  8.3.4. E-commerce
  8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Thin Film Drug Manufacturing Market Analysis and Forecast, by Region
  9.1. Key Findings
  9.2. Market Value Forecast, by Region, 2020-2034
  9.2.1. North America
  9.2.2. Europe
  9.2.3. Asia Pacific
  9.2.4. Latin America
  9.2.5. Middle East & Africa
  9.3. Market Attractiveness Analysis, by Region
10. North America Thin Film Drug Manufacturing Market Analysis and Forecast
  10.1. Introduction
  10.2. Key Findings
  10.3. Market Value Forecast, by Product, 2020-2034
  10.3.1. Oral Thin Film
  10.3.1.1. Sublingual Film
  10.3.1.2. Fully Dissolving Dental/Buccal Film
  10.3.2. Transdermal Thin Film
  10.3.3. Others
  10.4. Market Value Forecast, by Disease Indication, 2020-2034
  10.4.1. Schizophrenia
  10.4.2. Migraine
  10.4.3. Opioid Dependence
  10.4.4. Nausea & Vomiting
  10.4.5. Others
  10.5. Market Value Forecast, by Distribution Channel, 2020-2034
  10.5.1. Hospital Pharmacies
  10.5.2. Drug Stores
  10.5.3. Retail Pharmacies
  10.5.4. E-commerce
  10.6. Market Value Forecast, by Country, 2020-2034
  10.6.1. U.S.
  10.6.2. Canada
  10.7. Market Attractiveness Analysis
  10.7.1. By Product
  10.7.2. By Disease Indication
  10.7.3. By Distribution Channel
  10.7.4. By Country
11. Europe Thin Film Drug Manufacturing Market Analysis and Forecast
  11.1. Introduction
  11.2. Key Findings
  11.3. Market Value Forecast, by Product, 2020-2034
  11.3.1. Oral Thin Film
  11.3.1.1. Sublingual Film
  11.3.1.2. Fully Dissolving Dental/Buccal Film
  11.3.2. Transdermal Thin Film
  11.3.3. Others
  11.4. Market Value Forecast, by Disease Indication, 2020-2034
  11.4.1. Schizophrenia
  11.4.2. Migraine
  11.4.3. Opioid Dependence
  11.4.4. Nausea & Vomiting
  11.4.5. Others
  11.5. Market Value Forecast, by Distribution Channel, 2020-2034
  11.5.1. Hospital Pharmacies
  11.5.2. Drug Stores
  11.5.3. Retail Pharmacies
  11.5.4. E-commerce
  11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  11.6.1. Germany
  11.6.2. U.K.
  11.6.3. France
  11.6.4. Italy
  11.6.5. Spain
  11.6.6. Rest of Europe
  11.7. Market Attractiveness Analysis
  11.7.1. By Product
  11.7.2. By Disease Indication
  11.7.3. By Distribution Channel
  11.7.4. By Country/Sub-region
12. Asia Pacific Thin Film Drug Manufacturing Market Analysis and Forecast
  12.1. Introduction
  12.2. Key Findings
  12.3. Market Value Forecast, by Product, 2020-2034
  12.3.1. Oral Thin Film
  12.3.1.1. Sublingual Film
  12.3.1.2. Fully Dissolving Dental/Buccal Film
  12.3.2. Transdermal Thin Film
  12.3.3. Others
  12.4. Market Value Forecast, by Disease Indication, 2020-2034
  12.4.1. Schizophrenia
  12.4.2. Migraine
  12.4.3. Opioid Dependence
  12.4.4. Nausea & Vomiting
  12.4.5. Others
  12.5. Market Value Forecast, by Distribution Channel, 2020-2034
  12.5.1. Hospital Pharmacies
  12.5.2. Drug Stores
  12.5.3. Retail Pharmacies
  12.5.4. E-commerce
  12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  12.6.1. China
  12.6.2. Japan
  12.6.3. India
  12.6.4. Australia & New Zealand
  12.6.5. Rest of Asia Pacific
  12.7. Market Attractiveness Analysis
  12.7.1. By Product
  12.7.2. By Disease Indication
  12.7.3. By Distribution Channel
  12.7.4. By Country/Sub-region
13. Latin America Thin Film Drug Manufacturing Market Analysis and Forecast
  13.1. Introduction
  13.2. Key Findings
  13.3. Market Value Forecast, by Product, 2020-2034
  13.3.1. Oral Thin Film
  13.3.1.1. Sublingual Film
  13.3.1.2. Fully Dissolving Dental/Buccal Film
  13.3.2. Transdermal Thin Film
  13.3.3. Others
  13.4. Market Value Forecast, by Disease Indication, 2020-2034
  13.4.1. Schizophrenia
  13.4.2. Migraine
  13.4.3. Opioid Dependence
  13.4.4. Nausea & Vomiting
  13.4.5. Others
  13.5. Market Value Forecast, by Distribution Channel, 2020-2034
  13.5.1. Hospital Pharmacies
  13.5.2. Drug Stores
  13.5.3. Retail Pharmacies
  13.5.4. E-commerce
  13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  13.6.1. Brazil
  13.6.2. Mexico
  13.6.3. Rest of Latin America
  13.7. Market Attractiveness Analysis
  13.7.1. By Product
  13.7.2. By Disease Indication
  13.7.3. By Distribution Channel
  13.7.4. By Country/Sub-region
14. Middle East & Africa Thin Film Drug Manufacturing Market Analysis and Forecast
  14.1. Introduction
  14.2. Key Findings
  14.3. Market Value Forecast, by Product, 2020-2034
  14.3.1. Oral Thin Film
  14.3.1.1. Sublingual Film
  14.3.1.2. Fully Dissolving Dental/Buccal Film
  14.3.2. Transdermal Thin Film
  14.3.3. Others
  14.4. Market Value Forecast, by Disease Indication, 2020-2034
  14.4.1. Schizophrenia
  14.4.2. Migraine
  14.4.3. Opioid Dependence
  14.4.4. Nausea & Vomiting
  14.4.5. Others
  14.5. Market Value Forecast, by Distribution Channel, 2020-2034
  14.5.1. Hospital Pharmacies
  14.5.2. Drug Stores
  14.5.3. Retail Pharmacies
  14.5.4. E-commerce
  14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
  14.6.1. GCC Countries
  14.6.2. South Africa
  14.6.3. Rest of Middle East & Africa
  14.7. Market Attractiveness Analysis
  14.7.1. By Product
  14.7.2. By Disease Indication
  14.7.3. By Distribution Channel
  14.7.4. By Country/Sub-region
15. Competition Landscape
  15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  15.2. Market Share Analysis, by Company (2023)
  15.3. Company Profiles
  15.3.1. Pfizer, Inc.
  15.3.1.1. Company Overview
  15.3.1.2. Product Portfolio
  15.3.1.3. SWOT Analysis
  15.3.1.4. Financial Overview
  15.3.1.5. Strategic Overview
  15.3.2. Novartis AG
  15.3.2.1. Company Overview
  15.3.2.2. Product Portfolio
  15.3.2.3. SWOT Analysis
  15.3.2.4. Financial Overview
  15.3.2.5. Strategic Overview
  15.3.3. Wolters Kluwer
  15.3.3.1. Company Overview
  15.3.3.2. Product Portfolio
  15.3.3.3. SWOT Analysis
  15.3.3.4. Financial Overview
  15.3.3.5. Strategic Overview
  15.3.4. Solvay
  15.3.4.1. Company Overview
  15.3.4.2. Product Portfolio
  15.3.4.3. SWOT Analysis
  15.3.4.4. Financial Overview
  15.3.4.5. Strategic Overview
  15.3.5. AbbVie
  15.3.5.1. Company Overview
  15.3.5.2. Product Portfolio
  15.3.5.3. SWOT Analysis
  15.3.5.4. Financial Overview
  15.3.5.5. Strategic Overview
  15.3.6. Sumitomo Pharma Co., Ltd
  15.3.6.1. Company Overview
  15.3.6.2. Product Portfolio
  15.3.6.3. SWOT Analysis
  15.3.6.4. Financial Overview
  15.3.6.5. Strategic Overview
  15.3.7. IntelGenx Corp.
  15.3.7.1. Company Overview
  15.3.7.2. Product Portfolio
  15.3.7.3. SWOT Analysis
  15.3.7.4. Financial Overview
  15.3.7.5. Strategic Overview
  15.3.8. NAL Pharma
  15.3.8.1. Company Overview
  15.3.8.2. Product Portfolio
  15.3.8.3. SWOT Analysis
  15.3.8.4. Financial Overview
  15.3.8.5. Strategic Overview
  15.3.9. ZIM Laboratories Limited
  15.3.9.1. Company Overview
  15.3.9.2. Product Portfolio
  15.3.9.3. SWOT Analysis
  15.3.9.4. Financial Overview
  15.3.9.5. Strategic Overview
  15.3.10. Indivior PLC
  15.3.10.1. Company Overview
  15.3.10.2. Product Portfolio
  15.3.10.3. SWOT Analysis
  15.3.10.4. Financial Overview
  15.3.10.5. Strategic Overview
  15.3.11. MonoSol
  15.3.11.1. Company Overview
  15.3.11.2. Product Portfolio
  15.3.11.3. SWOT Analysis
  15.3.11.4. Financial Overview
  15.3.11.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings